Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 20 tags : Europe save search
LumiraDx receives approval for its COVID-19 Antigen Test for use in India
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
LMDX | $0.016 -15.0% 130M
|
|
| O: 20.4%
H: 3.25%
C: -6.7%
covid test india approval covid-19
Lixte Biotechnology to Discuss its Collaboration with Leading European Cancer Centers at the Benzinga Global Small Cap Conference on October 28
Published: 2021-10-20 (Crawled : 14:00) - globenewswire.com
LIXT | $3.351 4.68% 11K
|
Health Technology
|
| O: 0.52%
H: 1.56%
C: -5.73%
europe collaboration cancer biotech technology iot conference
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.64%
H: 0.71%
C: -2.76%
europe ongoing phase 1 therapy trial
Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy
Published: 2021-10-20 (Crawled : 13:00) - globenewswire.com
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: -0.65%
H: 1.54%
C: -6.58%
europe gene therapy positive therapy preclinical pre-clinical
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its Broad Genome Editing Capabilities at the 2021 European Society of Gene & Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 12:00) - globenewswire.com
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: 1.61%
H: 2.17%
C: -4.21%
europe genome editing therapy preclinical pre-clinical
RedHill Biopharma to Present at the BIO-Europe 2021 Conference
Published: 2021-10-20 (Crawled : 11:00) - prnewswire.com
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: 0.0%
H: 10.53%
C: 5.81%
biopharma europe conference presentation
Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2021-10-20 (Crawled : 10:00) - biospace.com/
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: 6.15%
H: 1.44%
C: -2.95%
treatment europe positive therapy trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.